Product Reports Resources Pricing Login Book a demo

Dexcom

Health Tech & Medtech · San Diego, United States · Founded 1999 · IPO 2005

Continuous Glucose Monitoring

Valuation $31B
Revenue $5.23B
EBITDA $1.66B

Investors

7 investors on Dexcom's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 7 investors entered at this stage
St. Paul Venture Capital
Canaan
Warburg Pincus
Windamere Venture Partners
Federated Hermes
Fog City Capital
RWI Group

Global footprint

Where Dexcom has talent and traffic

Workforce by country
38 countries with
team presence
🇺🇸 United States60.7%
🇵🇭 Philippines9.7%
🇲🇾 Malaysia8.7%
🇱🇹 Lithuania5.1%
🇬🇧 United Kingdom3.7%
Top 5 of 38 shown
Web traffic by country
2.5M monthly visits
across markets
🇺🇸 United States77%
🇩🇪 Germany3.5%
🇬🇧 United Kingdom2.3%
🇨🇦 Canada2.3%
🇦🇺 Australia2.1%
Top 5 markets shown

Talent graph

The shape of Dexcom's talent

Dealroom maps Dexcom's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

16 standout operatorsDealroom-flagged across the org
69 AI specialistsincl. 12 core researchers
8,882 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Dexcom's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$842M patent portfolio · 499 active families

Estimated portfolio value
$842M
2.7% of market cap · 116.1× larger than top peer Eight Sleep ($7M)
499 active patent families
Where Dexcom innovates AnalyteBiomedical engineeringData scienceElectronicsGlucose Measurement

Where Dexcom concentrates vs peers

Each axis is a top-10 topic across Dexcom and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Dexcom's 9 investments and acquisitions.

Every disclosed deal where Dexcom appeared as a backer or acquirer, 2012–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

9 deals across Dexcom's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Dexcom deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Dexcom's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        9 of 9 deals

        Market sentiment

        What the market is saying about Dexcom

        An AI-synthesized read of the highest-engagement posts about Dexcom on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Dexcom on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.